Keywords: Neurofluids, Alzheimer's Disease, Biomarker
Motivation: Perivascular space (PVS) enlargement is used to estimate the severity of glymphatic clearance dysfunction in Alzheimer’s disease. There is a lack of imaging tool to estimate the cerebral cortical PVS load.
Goal(s): Investigate the association between the MR T2-relaxometry based CSF fraction (CSFF), a measure of total PVS (including both MR visible and invisible PVS), and PET imaging based Aβ deposition.
Approach: Use 6-echo FAST-T2 image to map CSFF and correlate it with Aβ deposition in both cognitive normal and mild cognitive impaired groups.
Results: CSFF is better than PVS load in association with Aβ deposition in MCI/AD subjects.
Impact: Parenchymal CSF fraction measured using MR T2-relaxometry is an estimate of total perivascular space, which reflect glymphatic clearance function. It has superior performance in correlation with Aβ deposition than MRI based PVS segmentation.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords